Cited by 713Hormonal and reproductive studiesProstate Cancer Treatment and ResearchMenopause: Health Impacts and Treatments

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

Risks of testosterone-replacement therapy and recommendations for monitoring.

Rhoden, Ernani Luis, Morgentaler, Abraham·2004·New England Journal of Medicine

DOI 10.1056/nejmra022251

Open this paper in CoChat — free account

Abstract

Although some reports suggest that testosterone-replacement therapy may provide benefits for aging men, considerable controversy remains regarding indications for its use. Neither large-scale nor long-term studies have been initiated, in part because of theoretical concern regarding the risks associated with testosterone therapy, especially the possible stimulation of prostate cancer. This article discusses what is known (and not known) about the risks of testosterone-replacement therapy and provides recommendations for monitoring men who are receiving testosterone.

Integrity signals

Registry

Crossref · 10.1056/nejmra022251

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Estrogen plus Progestin and the Risk of Coronary Heart Disease
Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., Trevisan, M., Black, H. R., Heckbert, S. R., Detrano, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030808 · Cited by 2,065
STUDIES ON PROSTATIC CANCER
Huggins, C. (1941) · Archives of Surgery · doi:10.1001/archsurg.1941.01210140043004 · Cited by 1,694
Longitudinal Evaluation of Prostate-Specific Antigen Levels in Men With and Without Prostate Disease
Carter, H. B. (1992) · JAMA · doi:10.1001/jama.1992.03480160073037 · Cited by 1,076
Testosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
Sih, R., Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., & Ross, C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.3988 · Cited by 920
Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men
Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830
Prospective Study of Sex Hormone Levels and Risk of Prostate Cancer
Gann, P. H., Hennekens, C. H., Ma, J., Longcope, C., & Stampfer, M. J. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1118 · Cited by 782
The Frequency of Carcinoma and Intraepithelial Neoplasia of the Prostate in Young Male Patients
Sakr, W., Haas, G. P., Cassin, B. F., Pontes, J. E., & Crissman, J. D. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)35487-3 · Cited by 744
Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.
Huggins, C., & Hodges, C. (2002) · Journal of Urology · doi:10.1016/s0022-5347(02)80307-x · Cited by 637

Show all 77 references

Research works printed but not linked: 11

10.1210/jc.86.2.724 · DOI · Paper page
10.1210/jc.82.6.1661 · DOI
10.1210/jc.83.10.3443 · DOI
10.1210/jc.82.11.3793 · DOI
10.1210/jc.87.1.136 · DOI
10.1210/jc.87.4.1467 · DOI
Barrett-Connor EL, 1995, Diabetes Metab, 21, 156
2002, Endocr Rep, 2, 1
10.1210/jc.86.6.2380 · DOI
Westaby D, 1977, Lancet, 2, 262
10.1345/aph.1A020 · DOI · Paper page

Sorted by citations

Molecular and Cellular Basis of Cardiovascular Gender Differences
Mendelsohn, M. E., & Karas, R. H. (2005) · Science · doi:10.1126/science.1112062 · Cited by 1,105
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Investigation, treatment and monitoring of late-onset hypogonadism in males
Wang, C., Nieschlag, E., Swerdloff, R., Behre, H. M., Hellstrom, W. J., Gooren, L. J., Kaufman, J. M., Legros, J.-J., Lunenfeld, B., Morales, A., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0601 · Cited by 867
Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study
Khaw, K.-T., Dowsett, M., Folkerd, E., Bingham, S., Wareham, N., Luben, R., Welch, A., & Day, N. (2007) · Circulation · doi:10.1161/circulationaha.107.719005 · Cited by 743
Effect of Testosterone Supplementation on Functional Mobility, Cognition, and Other Parameters in Older Men: A Randomized Controlled Trial
Emmelot-Vonk, M. H., Verhaar, H. J. J., Nakhai Pour, H. R., Aleman, A., Lock, T. M. T. W., Bosch, J. L. H. R., Grobbee, D. E., & van der Schouw, Y. T. (2008) · JAMA · doi:10.1001/jama.2007.51 · Cited by 518
“A stimulatory effect of testosterone on erythropoiesis has been documented in several studies.(73) This effect was confirmed in our study, but without apparent clinical consequences.”
Low Serum Testosterone and Mortality in Male Veterans
Shores, M. M., Matsumoto, A. M., Sloan, K. L., & Kivlahan, D. R. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1660 · Cited by 489
Low testosterone levels are common and associated with insulin resistance in men with diabetes
Grossmann, M., Thomas, M. C., Panagiotopoulos, S., Sharpe, K., MacIsaac, R. J., Clarke, S., Zajac, J. D., & Jerums, G. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2177 · Cited by 468
Shifting the Paradigm of Testosterone and Prostate Cancer: The Saturation Model and the Limits of Androgen-Dependent Growth
Morgentaler, A., & Traish, A. M. (2008) · European Urology · doi:10.1016/j.eururo.2008.09.024 · Cited by 469
Investigation, Treatment, and Monitoring of Late‐Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations
Wang, C., Nieschlag, E., Swerdloff, R. S., Behre, H. M., Hellstrom, W. J. G., Gooren, L. J., Kaufman, J., Legros, J. J., Lunenfeld, B., Morales, Á., et al. (2008) · Journal of Andrology · doi:10.2164/jandrol.108.006486 · Cited by 443
Effect of Testosterone Replacement Therapy on Prostate Tissue in Men With Late-Onset Hypogonadism: A Randomized Controlled Trial
Marks, L. S., Mazer, N. A., Mostaghel, E., Hess, D. L., Dorey, F. J., Epstein, J. I., Veltri, R. W., Makarov, D. V., Partin, A. W., Bostwick, D. G., et al. (2006) · JAMA · doi:10.1001/jama.296.19.2351 · Cited by 400
The benefits and risks of testosterone replacement therapy: a review
Morley, J. E. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3025 · Cited by 381
Gender differences in the cardiovascular effect of sex hormones
Vitale, C., Mendelsohn, M. E., & Rosano, G. M. C. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.105 · Cited by 375
Investigation, Treatment, and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations
Wang, C., Nieschlag, E., Swerdloff, R. S., Behre, H. M., Hellstrom, W. J. G., Gooren, L. J., Kaufman, J., Legros, J.-J., Lunenfeld, B., Morales, Á., et al. (2008) · European Urology · doi:10.1016/j.eururo.2008.08.033 · Cited by 346
Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men
Lunenfeld, B., Mskhalaya, G. J., Zitzmann, M., Arver, S., Kalinchenko, S. Y., Tishova, Y. A., & Morgentaler, A. (2015) · The Aging Male · doi:10.3109/13685538.2015.1004049 · Cited by 318
Optimal management of sarcopenia
Sumukadas, D. (2010) · Clinical Interventions in Aging · doi:10.2147/cia.s11473 · Cited by 306
ISA, ISSAM, EAU, EAA and ASA recommendations: Investigation, treatment and monitoring of late-onset hypogonadism in males
Wang, C., Nieschlag, E., Swerdloff, R. S., Behre, H. M., Hellstrom, W. J. G., Gooren, L. J., Kaufman, J., Legros, J.-J., Lunenfeld, B., Morales, Á., et al. (2008) · International Journal of Impotence Research · doi:10.1038/ijir.2008.41 · Cited by 287
Testosterone Deficiency in Men: Systematic Review and Standard Operating Procedures for Diagnosis and Treatment
Buvat, J., Maggi, M., Guay, A. T., & Torres, L. O. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02783.x · Cited by 285
Low Testosterone Levels and the Risk of Anemia in Older Men and Women
Ferrucci, L., Maggio, M. G., Bandinelli, S., Basaria, S. S., Lauretani, F., Blè, A., Valenti, G., Ershler, W. B., Guralnik, J. M., & Longo, D. L. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.13.1380 · Cited by 271
Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial
Sinclair, M., Grossmann, M., Hoermann, R., Angus, P. W., & Gow, P. J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.007 · Cited by 269
Testosterone and erectile function: From basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction
Traish, A. M., Goldstein, I., & Kim, N. N. (2007) · European Urology · doi:10.1016/j.eururo.2007.02.034 · Cited by 268
Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study
Mohr, B. A., Guay, A. T., O’Donnell, A. B., & McKinlay, J. B. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02174.x · Cited by 248
Testosterone and Prostate Cancer: An Historical Perspective on a Modern Myth
Morgentaler, A. (2006) · European Urology · doi:10.1016/j.eururo.2006.06.034 · Cited by 247
Sexual Dysfunction and Cardiac Risk (the Second Princeton Consensus Conference)
Kostis, J. B., Jackson, G., Rosen, R. C., Barrett-Connor, E. L., Billups, K. L., Burnett, A. L. “., Carson, C. C., Cheitlin, M. D., DeBusk, R. F., Fonseca, V. A., et al. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.03.065 · Cited by 250
Investigation, treatment and monitoring of late‐onset hypogonadism in males
Wang, C., Nieschlag, E., Swerdloff, R. S., Behre, H. M., Hellstrom, W. J. G., Gooren, L. J., Kaufman, J., Legros, J. J., Lunenfeld, B., Morales, Á., et al. (2008) · International Journal of Andrology · doi:10.1111/j.1365-2605.2008.00924.x · Cited by 245
Investigation, treatment and monitoring of late-onset hypogonadism in males
Nieschlag, E., Swerdloff, R. S., Hm, B., Gooren, L. J., Kaufman, J., Legros, J.-J., Lunenfeld, B., Morley, J., Schulman, C., Wang, C., et al. (2005) · The Aging Male · doi:10.1080/13685530500130969 · Cited by 242
A practical guide to male hypogonadism in the primary care setting
Dandona, P., & Rosenberg, M. T. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02355.x · Cited by 225
TESTOSTERONE REPLACEMENT THERAPY AFTER PRIMARY TREATMENT FOR PROSTATE CANCER
Agarwal, P. K., & Oefelein, M. G. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000143942.55896.64 · Cited by 205
Hormonal and Metabolic Changes of Aging and the Influence of Lifestyle Modifications
Pataky, M. W., Young, W. F., & Nair, K. S. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.07.033 · Cited by 207
Serum Testosterone and the Risk of Prostate Cancer: Potential Implications for Testosterone Therapy
Parsons, J. K., Carter, H. B., Platz, E. A., Wright, E. J., Landis, P., & Metter, E. J. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0715 · Cited by 203
Testosterone for the aging male; current evidence and recommended practice
Jones, H. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s190 · Cited by 204
“Randomized controlled trials of testosterone treatment have found a low incidence of prostate cancer and they do not provide evidence of a link between testosterone treatment and the development of prostate cancer (Rhoden and Morgentaler 2004).”
Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence
Traish, A. M., & Guay, A. T. (2006) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2006.00245.x · Cited by 196
The Metabolic Syndrome and Disturbances in Hormone Levels in Long-Term Survivors of Disseminated Testicular Cancer
Nuver, J., Smit, A. J., Wolffenbuttel, B. H. R., Sluiter, W. J., Hoekstra, H. J., Sleijfer, D. T., & Gietema, J. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.176 · Cited by 194
Development of Focal Segmental Glomerulosclerosis after Anabolic Steroid Abuse
Herlitz, L., Markowitz, G. S., Farris, A. B., Schwimmer, J. A., Stokes, M. B., Kunis, C. L., Colvin, R. B., & D’Agati, V. D. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009040450 · Cited by 192
Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy
Sarosdy, M. F. (2006) · Cancer · doi:10.1002/cncr.22438 · Cited by 190
Low Serum Testosterone Increases Mortality Risk among Male Dialysis Patients
Carrero, J. J., Qureshi, A. R., Parini, P., Arver, S., Lindholm, B., Barany, P. F., Heimbürger, O., & Stenvinkel, P. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008060664 · Cited by 190
Testosterone Replacement Therapy in Patients with Prostate Cancer After Radical Prostatectomy
Pastuszak, A. W., Pearlman, A. M., Lai, W. S., Godoy, G., Sathyamoorthy, K., Liu, J. S., Miles, B. J., Lipshultz, L. I., & Khera, M. (2013) · Journal of Urology · doi:10.1016/j.juro.2013.02.002 · Cited by 183
Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies
Chan, S. M. H., Selemidis, S., Bozinovski, S., & Vlahos, R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.013 · Cited by 186
Erectile Dysfunction
McVary, K. T. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp067261 · Cited by 179
ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males
Wang, C., Nieschlag, E., Swerdloff, R. S., Behre, H. M., Hellstrom, W. J. G., Gooren, L. J., Kaufman, J., Legros, J.-J., Lunenfeld, B., Morales, Á., et al. (2008) · The Aging Male · doi:10.1080/13685530802389628 · Cited by 176
Prevention and Management of Postprostatectomy Sexual Dysfunctions Part 2: Recovery and Preservation of Erectile Function, Sexual Desire, and Orgasmic Function
Salonia, A., Burnett, A. L. “., Graefen, M., Hatzimouratidis, K., Montorsi, F., Mulhall, J. P., & Stief, C. G. (2012) · European Urology · doi:10.1016/j.eururo.2012.04.047 · Cited by 175
Sexual Dysfunction and Cardiac Risk (the Second Princeton Consensus Conference)
Kostis, J. B., Jackson, G., Rosen, R., Barrett-Connor, E. L., Billups, K., Burnett, A. L. “., Carson, C., Cheitlin, M., DeBusk, R. F., Fonseca, V. A., et al. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.018 · Cited by 173
Erythrocytosis Following Testosterone Therapy
Ohlander, S. J., Varghese, B., & Pastuszak, A. W. (2018) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.04.001 · Cited by 168
Testosterone Therapy in Men With Untreated Prostate Cancer
Morgentaler, A., Lipshultz, L. I., Bennett, R., Sweeney, M. O., Avila, D., & Khera, M. (2011) · The Journal of Urology · doi:10.1016/j.juro.2010.11.084 · Cited by 166
The Metabolic Syndrome and Disturbances in Hormone Levels in Long-Term Survivors of Disseminated Testicular Cancer
Nuver, J., Smit, A. J., Wolffenbuttel, B. H. R., Sluiter, W. J., Hoekstra, H. J., Sleijfer, D. T., & Gietema, J. A. (2006) · The Journal of Urology · doi:10.1016/s0022-5347(05)01043-8 · Cited by 163
Testosterone replacement therapy
Barbonetti, A., D’Andrea, S., & Francavilla, S. (2020) · Andrology · doi:10.1111/andr.12774 · Cited by 175
The International Society for Sexual Medicine's Process of Care for the Assessment and Management of Testosterone Deficiency in Adult Men
Dean, J. D., McMahon, C. G., Guay, A. T., Morgentaler, A., Althof, S. E., Becher, E. F., Bivalacqua, T. J., Burnett, A. L. “., Buvat, J., Meliegy, A. E., et al. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12952 · Cited by 159
The Effect of Opioid Therapy on Endocrine Function
Brennan, M. J. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.12.001 · Cited by 161
Elevated Testosterone Induces Apoptosis in Neuronal Cells
Estrada, M., Varshney, A., & Ehrlich, B. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603193200 · Cited by 156
Developing biomedical engineering technologies for reproductive medicine
Zhu, Y., Kong, B., Liu, R., & Zhao, Y. (2022) · Smart Medicine · doi:10.1002/smmd.20220006 · Cited by 156
Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review
Saad, F., Aversa, A., M. Isidori, A., & J. Gooren, L. (2012) · Current Diabetes Reviews · doi:10.2174/157339912799424573 · Cited by 148
Hypogonadism in the Aging Male Diagnosis, Potential Benefits, and Risks of Testosterone Replacement Therapy
Surampudi, P. N., Wang, C., & Swerdloff, R. S. (2012) · International Journal of Endocrinology · doi:10.1155/2012/625434 · Cited by 154
Gender differences in the cardiovascular effects of sex hormones
Vitale, C., Fini, M., Speziale, G., & Chierchia, S. L. (2010) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2010.00817.x · Cited by 152
Outcomes of clomiphene citrate treatment in young hypogonadal men
Katz, D. J., Nabulsi, O., Tal, R., & Mulhall, J. P. (2012) · BJU International · doi:10.1111/j.1464-410x.2011.10702.x · Cited by 142
Salivary testosterone: Associations with depression, anxiety disorders, and antidepressant use in a large cohort study
Giltay, E. J., Enter, D., Zitman, F. G., Penninx, B. W. J. H., PELT, J. V., Spinhoven, P., & Roelofs, K. (2012) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2011.11.014 · Cited by 149
“In some studies, a low androgen status has been associated with symptoms of fatigue, irritability, dysphoria, declining vigor, low vitality, sexual dysfunction in men [23–26] and women [27], and an increased risk of depressive symptoms and depression in most [28–30] but not all studies [31,32].”
Effects of Testosterone Supplementation on Depressive Symptoms and Sexual Dysfunction in Hypogonadal Men with the Metabolic Syndrome
Giltay, E. J., Tishova, Y. A., Mskhalaya, G. J., Gooren, L. J. G., Saad, F., & Kalinchenko, S. Y. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01859.x · Cited by 140
Osteoporosis after Solid Organ Transplantation
Maalouf, N. M., & Shane, E. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1978 · Cited by 140
Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate‐specific antigen (PSA) level: a meta‐analysis
Boyle, P., Koechlin, A., Bota, M., d’Onofrio, A., Zaridze, D. G., Perrin, P., Fitzpatrick, J. M., Burnett, A. L. “., & Boniol, M. (2016) · British Journal of Urology · doi:10.1111/bju.13417 · Cited by 138
Testosterone treatment comes of age: new options for hypogonadal men
Nieschlag, E. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02618.x · Cited by 137
Hormone Replacement Therapy and Physical Function in Healthy Older Men. Time to Talk Hormones?
Giannoulis, M. G., Martin, F. C., Nair, K. S., Umpleby, A. M., & Sonksen, P. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1002 · Cited by 132
Interaction Between Bone and Muscle in Older Persons with Mobility Limitations
Ferrucci, L., Baroni, M., Ranchelli, A., Lauretani, F., Maggio, M. G., Mecocci, P., & Ruggiero, C. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660690 · Cited by 136
Pharmacological and X-Ray Structural Characterization of a Novel Selective Androgen Receptor Modulator: Potent Hyperanabolic Stimulation of Skeletal Muscle with Hypostimulation of Prostate in Rats
Ostrowski, J., Kuhns, J. E., Lupisella, J. A., Manfredi, M. C., Beehler, B. C., Krystek, S. R., Bi, Y., Sun, C., Seethala, R., Golla, R., et al. (2006) · Endocrinology · doi:10.1210/en.2006-0843 · Cited by 131
In men older than 70 years, total testosterone remains stable while free testosterone declines with age. The Health in Men Study
Yeap, B. B., Almeida, O. P., Hyde, Z., Norman, P. E., Chubb, S. A. P., Jamrozik, K. D., & Flicker, L. A. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0714 · Cited by 126
A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men
Morris, P., Malkin, C., Channer, K., & Jones, T. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510241 · Cited by 122
Comparative effects of daily and weekly boron supplementation on plasma steroid hormones and proinflammatory cytokines
Naghii, M. R., Mofid, M., Asgari, A. R., Hedayati, M., & DANESHPOUR, M. S. (2010) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2010.10.001 · Cited by 125
Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant ER-α and GPER signalling
Williams, G. P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.12.017 · Cited by 121
How I treat late effects in adults after allogeneic stem cell transplantation
Savani, B. N., Griffith, M. L., Jagasia, S. M., & Lee, S. J. (2010) · Blood · doi:10.1182/blood-2010-10-263095 · Cited by 115
Letrozole once a week normalizes serum testosterone in obesity-related male hypogonadism
Loves, S., Ruinemans-Koerts, J., & de Boer, H. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0663 · Cited by 141
Testosterone and Prostate Cancer: Revisiting Old Paradigms
Hendrik Isbarn, A., Pinthus, J. H., Marks, L. S., Montorsi, F., Morales, Á., Morgentaler, A., & Schulman, C. (2009) · European Urology · doi:10.1016/j.eururo.2009.03.088 · Cited by 111
“In 2004, Rhoden and Morgentaler reported on the PCa incidence in seven TT trials, of which three were placebo controlled [62] .”
The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism
Karazindiyanoğlu, S., & Çayan, S. (2008) · The Aging Male · doi:10.1080/13685530802290438 · Cited by 109
ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: Scientific background and rationale
Lunenfeld, B., Saad, F., & Hoesl, C. E. (2005) · The Aging Male · doi:10.1080/13685530500163416 · Cited by 108
Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review
Shabsigh, R., Crawford, E. D., Nehra, A. X., & Slawin, K. M. (2008) · International Journal of Impotence Research · doi:10.1038/ijir.2008.31 · Cited by 106
Hypogonadism in Elderly Men — What to Do Until the Evidence Comes
Snyder, P. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmp038207 · Cited by 106
Andropause: is androgen replacement therapy indicated for the aging male?
Hijazi, R. A., & Cunningham, G. R. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104518 · Cited by 105
The Burden of Testosterone Deficiency Syndrome in Adult Men: Economic and Quality-of-Life Impact
Maggi, M., Schulman, C., Quinton, R., Langham, S., & Uhl-Hochgräber, K. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00531.x · Cited by 103
Does Testosterone Have a Role in Erectile Function?
Mikhail, N. E. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.07.042 · Cited by 103
Anabolic steroids, acute myocardial infarction and polycythemia: A case report and review of the literature
Stergiopoulos, K., Mathews, R., Brennan, J., Setaro, J. F., & Kort, S. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s4261 · Cited by 102
Adult-Onset Hypogonadism
Khera, M., Broderick, G. A., Carson, C. C., Dobs, A. S., Faraday, M. M., Goldstein, I., Hakim, L. S., Hellstrom, W. J. G., Kacker, R., Köhler, T. S., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.04.022 · Cited by 99
Testosterone Induces Cytoprotection by Activating ATP-Sensitive K + Channels in the Cardiac Mitochondrial Inner Membrane
Er, F., Michels, G., Gassanov, N., Rivero, F., & Hoppe, U. C. (2004) · Circulation · doi:10.1161/01.cir.0000146900.84943.e0 · Cited by 96
Sexual Health Inquiry and Support is a Primary Care Priority
D, R. S. M., & Nusbaum, M. R. H. (2006) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2005.00193.x · Cited by 98
Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging
Pierorazio, P. M., Ferrucci, L., Kettermann, A. E., Longo, D. L., Metter, E. J., & Carter, H. B. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08853.x · Cited by 94
The testosterone mimetic properties of icariin
Zhang, Z.-B., & Yang, Q. (2006) · Asian Journal of Andrology · doi:10.1111/j.1745-7262.2006.00197.x · Cited by 91
A randomized trial of adjunct testosterone for cancer‐related muscle loss in men and women
Wright, T. J., Dillon, E. L., Durham, W. J., Chamberlain, A., Randolph, K. M., Danesi, C. P., Horstman, A. M. H., Gilkison, C. R., Willis, M., Richardson, G., et al. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12295 · Cited by 89
A Review of Hypogonadism and Erectile Dysfunction Among HIV-Infected Men During the Pre- and Post-HAART Eras: Diagnosis, Pathogenesis, and Management
Crum, N. F., Furtek, K. J., Olson, P. E., Amling, C. L., & Wallace, M. R. (2005) · AIDS Patient Care and STDs · doi:10.1089/apc.2005.19.655 · Cited by 90
“82 There is also no evidence of an increased risk of heart disease 1 ; some studies have suggested a protective effect.”
Influential
Long-Term Effects of Dihydrotestosterone Treatment on Prostate Growth in Healthy, Middle-Aged Men Without Prostate Disease
Idan, A., Griffiths, K. A., Harwood, D. T., Seibel, M. J., Turner, L., Conway, A. J., & Handelsman, D. J. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-10-201011160-00004 · Cited by 89
Male hypogonadism. Part II: etiology, pathophysiology, and diagnosis
Seftel, A. D. (2005) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901365 · Cited by 89
Endocrinological derangements in COPD
Laghi, F. A., Adıgüzel, N., & Tobin, M. J. (2009) · European Respiratory Journal · doi:10.1183/09031936.00103708 · Cited by 92
Effects of Dehydroepiandrosterone and Flutamide on Hippocampal CA1 Spine Synapse Density in Male and Female Rats: Implications for the Role of Androgens in Maintenance of Hippocampal Structure
MacLusky, N. J., Hajszán, T., & Léránth, C. (2004) · Endocrinology · doi:10.1210/en.2004-0477 · Cited by 89
Risks of testosterone replacement therapy in men
Ramasamy, R., Osterberg, E. C., & Bernie, A. (2014) · Indian Journal of Urology · doi:10.4103/0970-1591.124197 · Cited by 92
Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results
Kacker, R., Hult, M., Francisco, I. S., Conners, W. P., Rojas, P. A., DeWolf, W. C., & Morgentaler, A. (2015) · Asian Journal of Andrology · doi:10.4103/1008-682x.160270 · Cited by 85
Testosterone and the aging male: To treat or not to treat?
Bain, J. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.01.009 · Cited by 84
Testosterone Therapy and Obstructive Sleep Apnea: Is There a Real Connection?
Hanafy, H. M. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00553.x · Cited by 84
The Role of Testosterone in the Etiology and Treatment of Obesity, the Metabolic Syndrome, and Diabetes Mellitus Type 2
Saad, F., & Gooren, L. J. (2010) · Journal of Obesity · doi:10.1155/2011/471584 · Cited by 82
Testosterone Replacement Therapy and Prostate Cancer
Morgentaler, A. (2007) · Urologic Clinics of North America · doi:10.1016/j.ucl.2007.08.002 · Cited by 82
Clomiphene Citrate for the Treatment of Hypogonadism
Wheeler, K. M., Sharma, D., Kavoussi, P. K., Smith, R. P., & Costabile, R. (2019) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2018.10.001 · Cited by 81
Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: Restoration instead of replacement
Kim, E. D., McCullough, A., & Kaminetsky, J. (2016) · BJU International · doi:10.1111/bju.13337 · Cited by 81
Testosterone therapy induces molecular programming augmenting physiological adaptations to resistance exercise in older men
Gharahdaghi, N., Rudrappa, S. S., Brook, M. S., IDRIS, I. R., Crossland, H., Hamrock, C., Aziz, M. H. A., Kadi, F., Tarum, J., Greenhaff, P. L., et al. (2019) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12472 · Cited by 88
Off-label use of hormones as an antiaging strategy: a review
Samaras, N., Papadopoulou, M.-A., Samaras, D., & Ongaro, F. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s48918 · Cited by 83
Discovery of Diarylhydantoins as New Selective Androgen Receptor Modulators
Nique, F., Hebbe, S., Peixoto, C., Annoot, D., Lefrançois, J.-M., Duval, E., Michoux, L., Triballeau, N., Lemoullec, J.-M., Mollat, P., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300249m · Cited by 80
Cardiovascular disease and androgens: A review
Kaushik, M., Sontineni, S. P., & Hunter, C. B. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.10.033 · Cited by 79
Hypogonadism in Men with Chronic Obstructive Pulmonary Disease
Laghi, F. A., Antonescu-Turcu, A., Collins, E. G., Segal, J. P., Tobin, D. E., Jubran, A., & Tobin, M. J. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200501-037oc · Cited by 79

Authors: Rhoden, E. L., & Morgentaler, A.
Affiliations: Beth Israel Deaconess Medical Center (US)
ORCID: Morgentaler, Abraham
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2004-01-29
Volume: 350
Issue: 5
Pages: 482-492
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra022251
OpenAlex: W2120158027
Cited by: 705
References: 77
Citations by year: 2026: 5 · 2025: 7 · 2024: 12 · 2023: 10 · 2022: 7 · 2021: 16 · 2020: 18 · 2019: 21 · 2018: 19 · 2017: 20 · 2016: 22 · 2015: 36 · 2014: 30 · 2013: 35 · 2012: 44
FWCI: 9.78
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords: testosterone replacement therapy, risk, prostate cancer, older men, monitoring, androgen therapy, hypogonadism
MeSH terms: Cardiovascular Diseases, Humans, Hypogonadism, Lipids, Male, Polycythemia, Prostatic Diseases, Risk Factors, Testosterone, Drug Monitoring, Prostate-Specific Antigen, Age Distribution, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Risks of testosterone-replacement therapy and recommendations for monitoring.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks